|Articles|August 2, 2017
WIRB-Copernicus Group Acquires Patient Genesis’ ConsentNow eConsent
Advertisement
WIRB-Copernicus Group (WCG)-provider of regulatory and ethical review services (IRB) for human research-announced its acquisition of Patient Genesis' ConsentNow eConsent technology for healthare, pharmaceutical, and medical device companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Partners for Success: Governance Best Practices to Streamline eCOA Trial Launch
2
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
3
2025 Veeva R&D and Quality Summit: Advancing Site Efficiency and Collaboration in the Next Era of Clinical Trials
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
